Article Details
Retrieved on: 2025-06-16 19:28:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley has adjusted its rating for Sarepta Therapeutics (SRPT), moving it from Overweight to Equal Weight. Alongside this downgrade ...
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here